Invention Grant
- Patent Title: Hybrid galactoside inhibitor of galectins
-
Application No.: US15323967Application Date: 2015-07-06
-
Publication No.: US10253059B2Publication Date: 2019-04-09
- Inventor: Hakon Leffler , Ulf Nilsson , Fredrik Zetterberg
- Applicant: GALECTO BIOTECH AB
- Applicant Address: DK Copenhagen
- Assignee: GALECTO BIOTECH AB
- Current Assignee: GALECTO BIOTECH AB
- Current Assignee Address: DK Copenhagen
- Agency: Agris & von Natzmer, LLP
- Agent Cheryl H Agris
- Priority: EP14176421 20140709; EP14177599 20140718
- International Application: PCT/EP2015/065313 WO 20150706
- International Announcement: WO2016/005311 WO 20160114
- Main IPC: C07H19/056
- IPC: C07H19/056 ; C07H13/04 ; C07H13/08 ; C07H15/26
Abstract:
The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
Public/Granted literature
- US20170349622A1 NOVEL HYBRID GALACTOSIDE INHIBITOR OF GALECTINS Public/Granted day:2017-12-07
Information query
IPC分类:
